BTSGHealthcare · Health Information ServicesThe 18 Wall Street analysts covering BrightSpring Health Services, Inc. hold a median 12-month price target of $80 — +32.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 93 of 100 as at 1 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores BrightSpring Health Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (96): The shares have been drifting up relative to others.
Volatility (49): The share price moves around a lot.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own BrightSpring Health Services, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on BTSG, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +32.3% from it.
Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 July 2026 | Keybanc | Maintains | Overweight | $60 → $80 |
| 14 July 2026 | Morgan Stanley | Maintains | Overweight | $71 → $80 |
| 13 July 2026 | Guggenheim | Initiates | Buy | $81 |
| 13 July 2026 | Wells Fargo | Maintains | Overweight | $61 → $78 |
| 10 July 2026 | Raymond James | Initiates | Outperform | $80 |
| 8 July 2026 | UBS | Maintains | Buy | $63 → $85 |
| 2 July 2026 | B of A Securities | Maintains | Buy | — |
| 22 June 2026 | BTIG | Maintains | Buy | — |
| 18 June 2026 | TD Cowen | Maintains | Buy | — |
| 8 June 2026 | Goldman Sachs | Initiates | Buy | — |
| 2 June 2026 | Morgan Stanley | Maintains | Overweight | — |
| 6 May 2026 | Morgan Stanley | Maintains | Overweight | — |
| 5 May 2026 | Mizuho | Maintains | Outperform | — |
| 4 May 2026 | BMO Capital | Maintains | Outperform | — |
| 4 May 2026 | BTIG | Maintains | Buy | — |
| 4 May 2026 | Keybanc | Maintains | Overweight | — |
| 4 May 2026 | Stephens & Co. | Maintains | Overweight | — |
| 4 May 2026 | TD Cowen | Maintains | Buy | — |
| 4 May 2026 | Wells Fargo | Maintains | Overweight | — |
| 19 Mar 2026 | BTIG | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 14% of US stocks
Cheaper than 74% of US stocks
Cheaper than 17% of US stocks
Cheaper than 13% of US stocks
Higher than 75% of US stocks
Higher than 91% of US stocks
Higher than 14% of US stocks
Higher than 54% of US stocks
Higher than 53% of US stocks
Higher than 71% of US stocks
Higher than 76% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BTSG appears on the weeks it earns a place.
BrightSpring Health Services reported Q2 earnings and revenue above estimates, driven by growth in its pharmacy and provider segments. The company also raised its 2026 outlook.
Why it matters — The earnings beat and raised 2026 guidance signal improving profitability and momentum in BrightSpring's core business lines.
BrightSpring Health Services held its Q2 2026 earnings call, during which management discussed the company's financial results and performance for the quarter.
Why it matters — Earnings calls provide direct insight from management into the company's operational performance and strategic direction.
Zacks Investment Research reviewed BrightSpring Health Services' Q2 2026 earnings, comparing key metrics against Wall Street estimates and year-ago figures.
Why it matters — This analysis helps BTSG watchers assess how the company's operational performance in the quarter measured up against analyst expectations and its own prior results.
BrightSpring Health Services reported Q2 2026 results that exceeded its baseline expectations, driven by growth in Pharmacy Solutions and Provider Services, and reaffirmed confidence in its updated full-year outlook.
Why it matters — The earnings beat and reaffirmed outlook signal that BrightSpring's core business segments are performing ahead of plan, which may reassure investors watching the company's growth trajectory.
BrightSpring Health Services, Inc. (BTSG) reported quarterly earnings of $0.45 per share, surpassing the Zacks Consensus Estimate of $0.37 per share and up from $0.22 per share a year earlier.
Why it matters — The results exceeded analyst expectations and showed year-over-year earnings growth, indicating stronger-than-anticipated quarterly performance for BTSG.
The 18 Wall Street analysts covering BrightSpring Health Services, Inc. have a median 12-month price target of $80, with estimates ranging from $58 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 18 analysts covering BrightSpring Health Services, Inc., 18 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BrightSpring Health Services, Inc. 93 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, BrightSpring Health Services, Inc. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (96 of 100).
No one can know that. What the data says: the median 12-month target from 18 analysts implies +32.3% from the last close, and Ticker Nerd's factor model ranks BrightSpring Health Services, Inc. 93 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering BrightSpring Health Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BTSG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $58 to $90 over the next 12 months.
BrightSpring Health Services, Inc. returned +207.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
BrightSpring Health Services, Inc. is a leading provider of comprehensive home- and community-based health services for complex populations requiring specialized and chronic care.
The most recent item we track (Zacks Investment Research, 3 Aug 2026): "BrightSpring Q2 Earnings Beat on Specialty Growth, '26 View Raised". BrightSpring Health Services reported Q2 earnings and revenue above estimates, driven by growth in its pharmacy and provider segments. The company also raised its 2026 outlook.
BrightSpring Health Services, Inc. is a leading provider of comprehensive home- and community-based health services for complex populations requiring specialized and chronic care. The company delivers integrated pharmacy and provider services, including supportive care, clinical solutions, home health care, hospice, behavioral and neuro rehabilitation, and pharmacy therapy management across various settings. It serves high-need patients, such as seniors, individuals with disabilities, and those under Medicare, Medicaid, or insured programs, emphasizing quality outcomes through best-in-class services and advanced technology. Notable features include electronic health record solutions like TaskMaster Pro and QuickMAR, data analytics, telehealth, smart home monitoring, and care management platforms that enable high-tech, high-touch care. BrightSpring Health Services, Inc. focuses on connecting people with caregivers to enhance well-being in home and community environments nationwide. Founded in 1974 and headquartered in Louisville, Kentucky, it plays a vital role in the healthcare sector by supporting medically complex individuals through innovative, patient-centered approaches.
CEO Mr. Jon B. Rousseau · 23,500 employees · United States · https://www.brightspringhealth.com